Eko Foundation Analysis Software with Transformers (EFAST) vs Tempus ECG-AF
AI Verdict
Choose Eko Foundation Analysis Software with Transformers (EFAST) if…
Choose EFAST if your clinical workflow requires real-time AI assistance during auscultation to immediately identify existing structural murmurs or atrial fibrillation. This tool is ideal for point-of-care diagnostics during routine exams, providing instant insights directly from a digital stethoscope.
View Eko Foundation Analysis Software with Transformers (EFAST) →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your focus is on proactively identifying older patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year. This algorithm is best integrated into systems that analyze standard 12-lead ECG recordings for risk stratification, rather than real-time diagnostic support during a physical exam.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | Tempus ECG-AF |
|---|---|---|
| Pricing | Subscription-based, contact for details | Contact vendor |
| Deployment | Unknown | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Foundation Analysis Software with Transformers (EFAST)EFAST offers a more direct and interactive user experience by integrating AI analysis into the real-time auscultation process with its digital stethoscopes. This provides immediate, actionable insights at the point of care, streamlining the clinician's workflow during an exam.
Clinical Value
TieBoth tools offer significant clinical value, but in different capacities. EFAST provides immediate diagnostic insights for two conditions at the point of care, while Tempus ECG-AF offers a crucial predictive risk assessment for future AFib in a specific population, enabling proactive care. The direct diagnostic utility of EFAST is balanced by the preventative potential of Tempus ECG-AF.
Pricing & Value
Tempus ECG-AFTempus ECG-AF clearly outlines a specific CMS reimbursement pathway with a defined Medicare rate, providing a transparent and tangible financial value proposition for healthcare providers. While EFAST is subscription-based, its pricing details are less transparent, and it does not explicitly mention direct reimbursement codes for its AI analysis.
Enterprise Readiness
Tempus ECG-AFBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA, and integration capabilities. However, Tempus ECG-AF's explicit compatibility with leading 12-lead ECG systems from GE and Philips suggests a more direct and streamlined integration into existing cardiology infrastructure prevalent in large healthcare enterprises.
Innovation
TieBoth tools showcase distinct and valuable innovations in cardiac AI. EFAST's real-time, integrated AI at the point of auscultation is groundbreaking for immediate diagnostic support, while Tempus ECG-AF's predictive algorithm for future AFib risk from existing ECG data is equally innovative for proactive patient management.
Support & Docs
Eko Foundation Analysis Software with Transformers (EFAST)Eko Health provides more transparent and detailed information regarding its support and documentation, including a dedicated Help Center with user manuals, FAQs, and various direct contact methods with specified response times and availability. Tempus AI's support information, while present, is less specific to the ECG-AF product and its documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | Tempus ECG-AF |
|---|---|---|
| Product Name | Eko Foundation Analysis Software with Transformers (EFAST) | Tempus ECG-AF |
| Company | Eko Health | Tempus AI, Inc. |
| Primary Function | Assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. | Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Key AI Detection Capabilities | AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation. | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months. |
| Target Patient Population/Use Case | Not specified | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. |
| Integration/Compatibility | Seamless integration with Eko digital stethoscopes (e.g., CORE 500); EMR integration. | Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems. |
Videos
Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Tempus ECG-AF.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or Tempus ECG-AF
Backers
Who funded each tool's parent company.